ArticlePlants (Basel, Switzerland)2025
24-Epibrassinolide Enhanced Plant Antioxidant System and Cadmium Bioavailability Under Soil Cadmium Stress.
Article in Plants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Soil cadmium pollution poses significant environmental risks, prompting global concern. Previous studies have demonstrated that 24-epibrassinolide (Brs) can enhance plant photosynthesis, thereby potentially improving the efficiency of soil cadmium remediation by increasing biomass. Therefore, this study investigated the use of Brs to enhance Cd remediation by willow and alfalfa. After four months, we analyzed soil physicochemical properties, plant physiological and biochemical responses, biomass, Cd fractionation, plant Cd concentrations, and bioaccumulation factor (BCF). Willow and alfalfa cultivation without Brs increased soil pH and carbonates, reduced the exchangeable Cd fractionation, and increased Cd bound to Fe-Mn oxides and organic matter (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.